ANDERSON MICHAEL S

Average Profitability
<0.0001%
Insider Buys Quantity
11
Insider Buys Sum
$921,315.00
Insider Sells Quantity
1
Insider Sells Sum
$79,953.08

Insider Activity of ANDERSON MICHAEL S

The largest purchase of all time was on 2016-03-14 and amounted to 20000 shares of Avadel Pharmaceuticals plc for $194,700.

The largest sale of all time was on 2018-08-10 and amounted to 16297 shares of Avadel Pharmaceuticals plc for $79,953.

Biography of ANDERSON MICHAEL S

No biography is available at this moment.

2018-08-10SaleAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
16,297
0.0439%
$4.91$79,953-49.49%
2018-06-26PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
5,000
0.0133%
$6.04$30,200-53.25%
2018-05-24PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
6,000
0.0162%
$6.44$38,640-52.09%
2017-12-07PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
10,000
0.0254%
$8.86$88,590-23.2%
2017-09-12PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
8,000
0.0214%
$9.79$78,360-16.48%
2017-05-19PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
5,000
0.0124%
$10.00$50,000-6.31%
2016-11-21PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
4,000
0.0096%
$10.64$42,548-8.04%
2016-09-02PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
4,000
0.0097%
$14.12$56,480-27.76%
2016-08-22PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
10,000
0.0239%
$14.30$142,957-29.07%
2016-05-12PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
10,000
0.0243%
$8.84$88,400+18.69%
2016-03-18PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Officer
10,000
0.0247%
$11.04$110,440-0.18%
2016-03-14PurchaseAvadel Pharmaceuticals plc
AVDL
Chief Executive Office
20,000
0.0461%
$9.73$194,700+5.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.